US Patent Issued to Venthera on Jan. 13 for "Topical phosphoinositide 3-kinase inhibitors" (New Jersey, Pennsylvania, New Hampshire Inventors)

ALEXANDRIA, Va., Jan. 13 -- United States Patent no. 12,522,614, issued on Jan. 13, was assigned to Venthera Inc. (Palo Alto, Calif.).

"Topical phosphoinositide 3-kinase inhibitors" was invented by Ahmed F. Abdel-Magid (Ambler, Pa.), Agis Kydonieus (Kendall Park, N.J.), Thomas Rossi (Portsmouth, N.H.) and Hock S. Tan (North Brunswick, N.J.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides compounds and topical formulations including the compounds for the treatment of vascular malformations, wherein the compounds are according to formula (I): wherein subscript m, L1, R1, and L1-R1 are as described herein."

The patent was filed on April 10, 2023, under Application No. 18/297,698. ...